Review





Similar Products

90
Active Motif anti-rna pol ii ser2p antibody
Anti Rna Pol Ii Ser2p Antibody, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-rna pol ii ser2p antibody/product/Active Motif
Average 90 stars, based on 1 article reviews
anti-rna pol ii ser2p antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Active Motif anti-rna pol ii ser2p
Anti Rna Pol Ii Ser2p, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-rna pol ii ser2p/product/Active Motif
Average 90 stars, based on 1 article reviews
anti-rna pol ii ser2p - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Active Motif ser2p pol ii antibody #61083
Ser2p Pol Ii Antibody #61083, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ser2p pol ii antibody #61083/product/Active Motif
Average 90 stars, based on 1 article reviews
ser2p pol ii antibody #61083 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Millipore ser2p pol ii 04-1571
Ser2p Pol Ii 04 1571, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ser2p pol ii 04-1571/product/Millipore
Average 90 stars, based on 1 article reviews
ser2p pol ii 04-1571 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Illumina Inc pol ii, pol ii ser2p, pol ii ser5p, and cstf2 chip–seq data in serum-treated hct-116 cells
Pol Ii, Pol Ii Ser2p, Pol Ii Ser5p, And Cstf2 Chip–Seq Data In Serum Treated Hct 116 Cells, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pol ii, pol ii ser2p, pol ii ser5p, and cstf2 chip–seq data in serum-treated hct-116 cells/product/Illumina Inc
Average 90 stars, based on 1 article reviews
pol ii, pol ii ser2p, pol ii ser5p, and cstf2 chip–seq data in serum-treated hct-116 cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc pol ii ser2p
Pol Ii Ser2p, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pol ii ser2p/product/Cell Signaling Technology Inc
Average 96 stars, based on 1 article reviews
pol ii ser2p - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

86
Danaher Inc rna pol ii ser2p
( A ) MSTN protein level was analysed in shScr, shBRD4-L and shBRD4-S cells. β-Actin was used as loading control. Images are representative of at least three biological replicates. Densitometric analysis was done to quantify MSTN expression relative to β-Actin from three independent experiments and is shown in the bar graph. Error bars correspond to the average ± SEM ( n = 3 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. *** p ≤ 0.001. ( B ) Tumour lysates from 2 independent RD shScr, shBRD4-L and shBRD4-S xenografts were analysed for BRD4, MHC and MSTN expression using Western blotting. β-Actin was used as loading control. ( C – E ) ChIP assay was performed to examine the enrichment of BRD4-L and BRD4-S isoforms ( C ), H3K9Ac ( D ) and RNA <t>Pol</t> <t>II</t> ( E ) on the MSTN promoter relative to IgG control. The values were plotted as percentage of input, the average ± SEM is shown (n = 4 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. **** p ≤ 0.0001. ( F , G ) ChIP assay to examine the enrichment of BRD4-L ( F ) and RNA Pol II ( G ) in shBRD4-L and shBRD4-S compared to shScr control cells on MSTN promoter. The values were plotted as percentage of input, average ± SEM ( n = 4 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. **** p ≤ 0.0001, n.s. not significant. ( H ) BrdU assay in shScr, shBRD4-L and shBRD4-S cells and treated with or without 1 μg/ml of recombinant myostatin protein for 72 h. Nuclei were stained with DAPI (blue). Images are representative of at least three biological replicates. Scale bar: 100 μm. Scatter plot showing the percentage of BrdU + cells in shBRD4-L, shBRD4-S in comparison with shScr cells treated with or without recombinant myostatin protein. The values correspond to the average ± SEM ( n = 3 biological replicates with 3 technical replicates shown). Statistical significance was calculated by one-way ANOVA analysis. **** p ≤ 0.0001. ( I ) shScr, shBRD4-L and shBRD4-S cells were cultured in differentiation media in the absence or presence of 1 μg/ml of recombinant myostatin protein for 72 h. MHC + cells were analysed by immunofluorescence with anti-MHC antibody. Images are representative of at least three biological replicates. Scale bar: 100 μm. Scatter plot indicating MHC + cells in shBRD4-L, shBRD4-S in comparison with shScr cells with or without recombinant myostatin protein. The values correspond to the average ± SEM ( n = 3 biological replicates with 3 technical replicates shown). Statistical significance was calculated by one-way ANOVA analysis. **** p ≤ 0.0001. ( J ) Western blot analysis indicating protein expression of MHC and MSTN in shScr, shBRD4-L and shBRD4-S cells with or without recombinant myostatin protein for 72 h. β-Actin was used as loading control. .
Rna Pol Ii Ser2p, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rna pol ii ser2p/product/Danaher Inc
Average 86 stars, based on 1 article reviews
rna pol ii ser2p - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

90
DIAGENODE DIAGNOSTICS pol ii-ser2p diagenode c15200005 antibody
( A ) MSTN protein level was analysed in shScr, shBRD4-L and shBRD4-S cells. β-Actin was used as loading control. Images are representative of at least three biological replicates. Densitometric analysis was done to quantify MSTN expression relative to β-Actin from three independent experiments and is shown in the bar graph. Error bars correspond to the average ± SEM ( n = 3 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. *** p ≤ 0.001. ( B ) Tumour lysates from 2 independent RD shScr, shBRD4-L and shBRD4-S xenografts were analysed for BRD4, MHC and MSTN expression using Western blotting. β-Actin was used as loading control. ( C – E ) ChIP assay was performed to examine the enrichment of BRD4-L and BRD4-S isoforms ( C ), H3K9Ac ( D ) and RNA <t>Pol</t> <t>II</t> ( E ) on the MSTN promoter relative to IgG control. The values were plotted as percentage of input, the average ± SEM is shown (n = 4 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. **** p ≤ 0.0001. ( F , G ) ChIP assay to examine the enrichment of BRD4-L ( F ) and RNA Pol II ( G ) in shBRD4-L and shBRD4-S compared to shScr control cells on MSTN promoter. The values were plotted as percentage of input, average ± SEM ( n = 4 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. **** p ≤ 0.0001, n.s. not significant. ( H ) BrdU assay in shScr, shBRD4-L and shBRD4-S cells and treated with or without 1 μg/ml of recombinant myostatin protein for 72 h. Nuclei were stained with DAPI (blue). Images are representative of at least three biological replicates. Scale bar: 100 μm. Scatter plot showing the percentage of BrdU + cells in shBRD4-L, shBRD4-S in comparison with shScr cells treated with or without recombinant myostatin protein. The values correspond to the average ± SEM ( n = 3 biological replicates with 3 technical replicates shown). Statistical significance was calculated by one-way ANOVA analysis. **** p ≤ 0.0001. ( I ) shScr, shBRD4-L and shBRD4-S cells were cultured in differentiation media in the absence or presence of 1 μg/ml of recombinant myostatin protein for 72 h. MHC + cells were analysed by immunofluorescence with anti-MHC antibody. Images are representative of at least three biological replicates. Scale bar: 100 μm. Scatter plot indicating MHC + cells in shBRD4-L, shBRD4-S in comparison with shScr cells with or without recombinant myostatin protein. The values correspond to the average ± SEM ( n = 3 biological replicates with 3 technical replicates shown). Statistical significance was calculated by one-way ANOVA analysis. **** p ≤ 0.0001. ( J ) Western blot analysis indicating protein expression of MHC and MSTN in shScr, shBRD4-L and shBRD4-S cells with or without recombinant myostatin protein for 72 h. β-Actin was used as loading control. .
Pol Ii Ser2p Diagenode C15200005 Antibody, supplied by DIAGENODE DIAGNOSTICS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pol ii-ser2p diagenode c15200005 antibody/product/DIAGENODE DIAGNOSTICS
Average 90 stars, based on 1 article reviews
pol ii-ser2p diagenode c15200005 antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


( A ) MSTN protein level was analysed in shScr, shBRD4-L and shBRD4-S cells. β-Actin was used as loading control. Images are representative of at least three biological replicates. Densitometric analysis was done to quantify MSTN expression relative to β-Actin from three independent experiments and is shown in the bar graph. Error bars correspond to the average ± SEM ( n = 3 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. *** p ≤ 0.001. ( B ) Tumour lysates from 2 independent RD shScr, shBRD4-L and shBRD4-S xenografts were analysed for BRD4, MHC and MSTN expression using Western blotting. β-Actin was used as loading control. ( C – E ) ChIP assay was performed to examine the enrichment of BRD4-L and BRD4-S isoforms ( C ), H3K9Ac ( D ) and RNA Pol II ( E ) on the MSTN promoter relative to IgG control. The values were plotted as percentage of input, the average ± SEM is shown (n = 4 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. **** p ≤ 0.0001. ( F , G ) ChIP assay to examine the enrichment of BRD4-L ( F ) and RNA Pol II ( G ) in shBRD4-L and shBRD4-S compared to shScr control cells on MSTN promoter. The values were plotted as percentage of input, average ± SEM ( n = 4 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. **** p ≤ 0.0001, n.s. not significant. ( H ) BrdU assay in shScr, shBRD4-L and shBRD4-S cells and treated with or without 1 μg/ml of recombinant myostatin protein for 72 h. Nuclei were stained with DAPI (blue). Images are representative of at least three biological replicates. Scale bar: 100 μm. Scatter plot showing the percentage of BrdU + cells in shBRD4-L, shBRD4-S in comparison with shScr cells treated with or without recombinant myostatin protein. The values correspond to the average ± SEM ( n = 3 biological replicates with 3 technical replicates shown). Statistical significance was calculated by one-way ANOVA analysis. **** p ≤ 0.0001. ( I ) shScr, shBRD4-L and shBRD4-S cells were cultured in differentiation media in the absence or presence of 1 μg/ml of recombinant myostatin protein for 72 h. MHC + cells were analysed by immunofluorescence with anti-MHC antibody. Images are representative of at least three biological replicates. Scale bar: 100 μm. Scatter plot indicating MHC + cells in shBRD4-L, shBRD4-S in comparison with shScr cells with or without recombinant myostatin protein. The values correspond to the average ± SEM ( n = 3 biological replicates with 3 technical replicates shown). Statistical significance was calculated by one-way ANOVA analysis. **** p ≤ 0.0001. ( J ) Western blot analysis indicating protein expression of MHC and MSTN in shScr, shBRD4-L and shBRD4-S cells with or without recombinant myostatin protein for 72 h. β-Actin was used as loading control. .

Journal: EMBO Reports

Article Title: BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma

doi: 10.1038/s44319-023-00033-1

Figure Lengend Snippet: ( A ) MSTN protein level was analysed in shScr, shBRD4-L and shBRD4-S cells. β-Actin was used as loading control. Images are representative of at least three biological replicates. Densitometric analysis was done to quantify MSTN expression relative to β-Actin from three independent experiments and is shown in the bar graph. Error bars correspond to the average ± SEM ( n = 3 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. *** p ≤ 0.001. ( B ) Tumour lysates from 2 independent RD shScr, shBRD4-L and shBRD4-S xenografts were analysed for BRD4, MHC and MSTN expression using Western blotting. β-Actin was used as loading control. ( C – E ) ChIP assay was performed to examine the enrichment of BRD4-L and BRD4-S isoforms ( C ), H3K9Ac ( D ) and RNA Pol II ( E ) on the MSTN promoter relative to IgG control. The values were plotted as percentage of input, the average ± SEM is shown (n = 4 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. **** p ≤ 0.0001. ( F , G ) ChIP assay to examine the enrichment of BRD4-L ( F ) and RNA Pol II ( G ) in shBRD4-L and shBRD4-S compared to shScr control cells on MSTN promoter. The values were plotted as percentage of input, average ± SEM ( n = 4 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. **** p ≤ 0.0001, n.s. not significant. ( H ) BrdU assay in shScr, shBRD4-L and shBRD4-S cells and treated with or without 1 μg/ml of recombinant myostatin protein for 72 h. Nuclei were stained with DAPI (blue). Images are representative of at least three biological replicates. Scale bar: 100 μm. Scatter plot showing the percentage of BrdU + cells in shBRD4-L, shBRD4-S in comparison with shScr cells treated with or without recombinant myostatin protein. The values correspond to the average ± SEM ( n = 3 biological replicates with 3 technical replicates shown). Statistical significance was calculated by one-way ANOVA analysis. **** p ≤ 0.0001. ( I ) shScr, shBRD4-L and shBRD4-S cells were cultured in differentiation media in the absence or presence of 1 μg/ml of recombinant myostatin protein for 72 h. MHC + cells were analysed by immunofluorescence with anti-MHC antibody. Images are representative of at least three biological replicates. Scale bar: 100 μm. Scatter plot indicating MHC + cells in shBRD4-L, shBRD4-S in comparison with shScr cells with or without recombinant myostatin protein. The values correspond to the average ± SEM ( n = 3 biological replicates with 3 technical replicates shown). Statistical significance was calculated by one-way ANOVA analysis. **** p ≤ 0.0001. ( J ) Western blot analysis indicating protein expression of MHC and MSTN in shScr, shBRD4-L and shBRD4-S cells with or without recombinant myostatin protein for 72 h. β-Actin was used as loading control. .

Article Snippet: ChIP was conducted with 2 µg of IgG or purified antibodies against BRD4-L (Cat. #: 13440S, CST, 1:50), H3K9Ac (Cat. #: ab4441, Abcam) and RNA Pol II (Ser2P) (Cat. #: ab193468, Abcam) or 1 µg of BRD4-S (Wu et al, ) and analysed by qPCR using 4% of IP products and 0.2% of input DNA.

Techniques: Expressing, Two Tailed Test, Western Blot, BrdU Staining, Recombinant, Staining, Comparison, Cell Culture, Immunofluorescence

( A ) Western blot analysis of ITGA4 and ITGA5 in shScr, shBRD4-L and shBRD4-S cells. β-Actin was used as loading control. Images are representative of at least three biological replicates. ITGA4 and ITGA5 expression relative to β-Actin from three independent experiments was quantified densitometrically and is shown in the bar graph. Error bars correspond to the average ± SEM ( n = 3 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. *** p ≤ 0.001. ( B ) Tumour lysates from 2 independent NOD/SCID mice from tail vein assays were analysed for expression of ITGA4 and ITGA5 using Western blotting. β-Actin was used as loading control. ( C ) ChIP assay was performed to examine the enrichment of BRD4-L and BRD4-S on ITGA4 and ITGA5 promoter, IgG was used as a control. The values were plotted as percentage of input, average ± SEM ( n = 4 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. ** p ≤ 0.01, **** p ≤ 0.0001. ( D , E ) ChIP assay was performed to examine the enrichment of H3K9Ac ( D ) and RNA Pol II ( E ) on the ITGA4 and ITGA5 promoter. The values were plotted as percentage of input, average ± SEM ( n = 4 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. *** p ≤ 0.001, n.s. = not significant. ( F – H ) Enrichment of BRD4-L ( F ), BRD4-S ( G ) and RNA Pol II ( H ) in shScr, shBRD4-L and shBRD4-S cells at the ITGA4 and ITGA5 promoter was analysed by ChIP assay The values were plotted as percentage of input, the average ± SEM ( n = 4 biological replicates) is shown. Two-tailed non-parametric unpaired t test was performed for statistical analysis. n.s. not significant, ** p ≤ 0.01, *** p ≤ 0.001 and **** p ≤ 0.0001. ( I ) Upon transient knockdown of BRD4-L in shBRD4-S cells for 48 h, migratory and invasive capacity of shScr, shBRD4-L and shBRD4-S cells was analysed using transwell assay. The inserts were stained with crystal violet. Images are representative of at least three biological replicates. Scale bar: 100 μm. Scatter plots show the percentage of migrated and invaded shScr, shBRD4-L, shBRD4-S and shBRD4-S + siBRD4-L cells after 48 h. The values correspond to the average ± SEM ( n = 5 biological replicates with 2 technical replicates shown). Statistical significance was calculated by one-way ANOVA analysis. **** p ≤ 0.0001. ( J ) Western blot analysis of ITGA4 and ITGA5 in shScr, shBRD4-L, shBRD4-S and shBRD4-S + siBRD4-L. β-Actin was used as loading control. .

Journal: EMBO Reports

Article Title: BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma

doi: 10.1038/s44319-023-00033-1

Figure Lengend Snippet: ( A ) Western blot analysis of ITGA4 and ITGA5 in shScr, shBRD4-L and shBRD4-S cells. β-Actin was used as loading control. Images are representative of at least three biological replicates. ITGA4 and ITGA5 expression relative to β-Actin from three independent experiments was quantified densitometrically and is shown in the bar graph. Error bars correspond to the average ± SEM ( n = 3 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. *** p ≤ 0.001. ( B ) Tumour lysates from 2 independent NOD/SCID mice from tail vein assays were analysed for expression of ITGA4 and ITGA5 using Western blotting. β-Actin was used as loading control. ( C ) ChIP assay was performed to examine the enrichment of BRD4-L and BRD4-S on ITGA4 and ITGA5 promoter, IgG was used as a control. The values were plotted as percentage of input, average ± SEM ( n = 4 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. ** p ≤ 0.01, **** p ≤ 0.0001. ( D , E ) ChIP assay was performed to examine the enrichment of H3K9Ac ( D ) and RNA Pol II ( E ) on the ITGA4 and ITGA5 promoter. The values were plotted as percentage of input, average ± SEM ( n = 4 biological replicates). Two-tailed non-parametric unpaired t test was performed for statistical analysis. *** p ≤ 0.001, n.s. = not significant. ( F – H ) Enrichment of BRD4-L ( F ), BRD4-S ( G ) and RNA Pol II ( H ) in shScr, shBRD4-L and shBRD4-S cells at the ITGA4 and ITGA5 promoter was analysed by ChIP assay The values were plotted as percentage of input, the average ± SEM ( n = 4 biological replicates) is shown. Two-tailed non-parametric unpaired t test was performed for statistical analysis. n.s. not significant, ** p ≤ 0.01, *** p ≤ 0.001 and **** p ≤ 0.0001. ( I ) Upon transient knockdown of BRD4-L in shBRD4-S cells for 48 h, migratory and invasive capacity of shScr, shBRD4-L and shBRD4-S cells was analysed using transwell assay. The inserts were stained with crystal violet. Images are representative of at least three biological replicates. Scale bar: 100 μm. Scatter plots show the percentage of migrated and invaded shScr, shBRD4-L, shBRD4-S and shBRD4-S + siBRD4-L cells after 48 h. The values correspond to the average ± SEM ( n = 5 biological replicates with 2 technical replicates shown). Statistical significance was calculated by one-way ANOVA analysis. **** p ≤ 0.0001. ( J ) Western blot analysis of ITGA4 and ITGA5 in shScr, shBRD4-L, shBRD4-S and shBRD4-S + siBRD4-L. β-Actin was used as loading control. .

Article Snippet: ChIP was conducted with 2 µg of IgG or purified antibodies against BRD4-L (Cat. #: 13440S, CST, 1:50), H3K9Ac (Cat. #: ab4441, Abcam) and RNA Pol II (Ser2P) (Cat. #: ab193468, Abcam) or 1 µg of BRD4-S (Wu et al, ) and analysed by qPCR using 4% of IP products and 0.2% of input DNA.

Techniques: Western Blot, Expressing, Two Tailed Test, Transwell Assay, Staining